Huafei Li

649 total citations
24 papers, 326 citations indexed

About

Huafei Li is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Huafei Li has authored 24 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomaterials, 7 papers in Molecular Biology and 5 papers in Biomedical Engineering. Recurrent topics in Huafei Li's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers) and Immunotherapy and Immune Responses (4 papers). Huafei Li is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers) and Immunotherapy and Immune Responses (4 papers). Huafei Li collaborates with scholars based in China, United States and United Kingdom. Huafei Li's co-authors include Cong Wu, Yajun Guo, Hai Jin, Wei Wan, Jie Gao, Lixin Wei, Hao Wang, Jianxin Dai, Huafeng Wei and Li Zhang and has published in prestigious journals such as Biomaterials, Scientific Reports and IEEE Access.

In The Last Decade

Huafei Li

22 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huafei Li China	12	159	133	112	50	50	24	326
Juan J. Arroyo‐Crespo Spain	7	150 0.9×	164 1.2×	140 1.3×	63 1.3×	35 0.7×	9	366
Lisa Belfiore Australia	9	234 1.5×	184 1.4×	177 1.6×	70 1.4×	61 1.2×	12	480
Deise L. Chesca Brazil	6	178 1.1×	163 1.2×	103 0.9×	93 1.9×	66 1.3×	8	386
Joseph J. Bellucci United States	7	207 1.3×	172 1.3×	98 0.9×	70 1.4×	18 0.4×	7	381
Yinping Sun China	11	162 1.0×	145 1.1×	174 1.6×	57 1.1×	67 1.3×	20	394
Shweta Sharma United States	9	259 1.6×	215 1.6×	179 1.6×	101 2.0×	53 1.1×	11	491
Suyog Shaha United States	5	103 0.6×	128 1.0×	167 1.5×	41 0.8×	30 0.6×	7	302
Yinghao Ding China	11	187 1.2×	157 1.2×	146 1.3×	52 1.0×	57 1.1×	20	351
Fangbo Cui China	7	161 1.0×	175 1.3×	145 1.3×	46 0.9×	34 0.7×	10	359
Dianlong Jia China	12	180 1.1×	80 0.6×	104 0.9×	79 1.6×	57 1.1×	27	357

Countries citing papers authored by Huafei Li

Since Specialization

Citations

This map shows the geographic impact of Huafei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huafei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huafei Li more than expected).

Fields of papers citing papers by Huafei Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huafei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huafei Li. The network helps show where Huafei Li may publish in the future.

Co-authorship network of co-authors of Huafei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huafei Li. A scholar is included among the top collaborators of Huafei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huafei Li. Huafei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hui, Yan Gong, Yamei Liu, et al.. (2024). Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation. Theranostics. 14(11). 4375–4392. 6 indexed citations

Tian, Yuan, et al.. (2024). A protracted war against cancer drug resistance. Cancer Cell International. 24(1). 326–326. 12 indexed citations

Li, Huafei, et al.. (2024). Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report. Frontiers in Oncology. 14. 1346290–1346290. 1 indexed citations

Yang, Jian, et al.. (2024). Deep Learning Automatic Sleep Staging Method Based on Multidimensional Sleep Data. IEEE Access. 12. 168360–168369.

Huan, Weiwei, Huafei Li, Wei Liu, et al.. (2024). Sustainable gambogic acid release via pH/Redox Dual-Responsive C60-Modified magnetic mesoporous nanospheres for antitumor therapy. Materials & Design. 241. 112911–112911.

Wang, Changnan, et al.. (2024). "Yin-Yang philosophy" for the design of anticancer drug delivery nanoparticles.. PubMed. 5(2). 144–156. 5 indexed citations

Yang, Yuxiang, Bo Zhao, Huafei Li, et al.. (2022). Dual-targeting magnetic fluorescent mesoporous organosilicon hollow nanospheres for gambogic acid loading, sustained release and anti-tumor properties. Journal of Molecular Liquids. 360. 119412–119412. 11 indexed citations

Zhu, Ji, Qijue Lu, Bin Li, et al.. (2021). Potential of the cell‑free blood‑based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma. Oncology Letters. 22(1). 520–520. 3 indexed citations

Peng, Rong, Bangrang Di, Paul Glover, et al.. (2020). Seismo-electric conversion in shale: experiment and analytical modelling. Geophysical Journal International. 223(2). 725–745. 8 indexed citations

10.

Li, Huafei, et al.. (2020). Ursodeoxycholic acid protects against lung injury induced by fat embolism syndrome. Journal of Cellular and Molecular Medicine. 24(24). 14626–14632. 15 indexed citations

11.

Li, Huafei, Hai Jin, Wei Wan, Cong Wu, & Lixin Wei. (2018). Cancer Nanomedicine: Mechanisms, Obstacles and Strategies. Nanomedicine. 13(13). 1639–1656. 45 indexed citations

12.

Zhu, Ji, Cong Wu, Huafei Li, et al.. (2016). DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3. Tumor Biology. 37(7). 9781–9788. 16 indexed citations

13.

Li, Huafei, Yun Sun, Di Chen, et al.. (2015). Synergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity. Scientific Reports. 5(1). 15712–15712. 19 indexed citations

14.

Wu, Cong, Huafei Li, He Zhao, et al.. (2014). Potentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery. Nanoscale Research Letters. 9(1). 447–447. 21 indexed citations

15.

Zhao, Lei, Xin Tong, Huafei Li, et al.. (2014). Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20–243 CrossMab. mAbs. 6(3). 739–747. 15 indexed citations

16.

Li, Wei, Huafeng Wei, Huafei Li, et al.. (2014). Cancer Nanoimmunotherapy Using Advanced Pharmaceutical Nanotechnology. Nanomedicine. 9(16). 2587–2605. 30 indexed citations

17.

Li, Wei, Li Zhang, Ge Zhang, et al.. (2013). The Finely Regulating Well-defined Functional Polymeric Nanocarriers for Anti-tumor Immunotherapy. Mini-Reviews in Medicinal Chemistry. 13(5). 643–652. 7 indexed citations

18.

Li, Wei, Huafei Li, Huajing Wang, et al.. (2012). Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors. International Journal of Nanomedicine. 7. 4661–4661. 26 indexed citations

19.

Li, Wei, He Zhao, Weizhu Qian, et al.. (2012). Chemotherapy for gastric cancer by finely tailoring anti-Her2 anchored dual targeting immunomicelles. Biomaterials. 33(21). 5349–5362. 57 indexed citations

20.

Shen, Jia, et al.. (2010). Heterogeneous multi-layer access and RRM for the internet of things. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact